← Back to Newsletter Archive

Greetings!

Welcome to the Monthly QPS Preclinical Newsletter


This month, discover more about oligonucleotide drug development, uncover QPS toxicology studies, and catch up on the latest breakthroughs and insights on the QPS blog.

Targeted Therapies Using Oligonucleotides

QPS has supported gene therapy development since 2002, offering custom-built quantitation methods and precision bioanalysis for oligonucleotide therapeutics.


From PK and ADME, to immunogenicity and biodistribution, QPS scientists are ready to guide your oligonucleotide drug development with fully compliant data packages.

QPS Offers Toxicology Studies

Agility. Flexibility. Speed.


QPS delivers expert-led toxicity studies to accelerate your drug development studies through preclinical to regulatory submission, offering a full suite of services including:


  • General Toxicology
  • Genetic Toxicology
  • Reproductive Toxicology
  • Clinical Pathology
  • Histopathology
  • Biocompatibility Test for Medical Devices
  • Dermal Irritation and Contact Sensitization
  • Wound Healing

Discover the Future of Science on the QPS Blog

Improve Your Diet One Bite at a Time

 

You’ve heard it a thousand times: “Eat less, move more.” But when it comes to nutrition, eating less isn’t always better — at least,…



Plant-Based Diets and Heart Health

Clinical Services at QPS

Cracking Cancer’s Spread: New Target Identified to Block Bone Metastasis

 

Cancer’s cruelest trick might be its ability to migrate from its initial site and invade other organs and systems, with bones being one of…

 

Promising Pathways to Intervention

Oncology Research at QPS

Visit our website www.qps.com 

or contact us at infopr@qps.com

to start your next study.

Linkedin  Youtube  Twitter  Facebook  

www.qps.cominfopr@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)
← Back to Newsletter Archive